EM-T3Pharmacoepidemiology and Drug Safety2018-09-25第 27 卷第 11 期,1239-1248开放获取高影响力 · 前 10%
Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France